Skip to content
The U.S. Food and Drug Administration (FDA) granted traditional approval to the groundbreaking Alzheimer’s drug LEQEMBI, the first in a new class of Alzheimer’s […]
FDA grants traditional approval to LEQEMBI Read More »
According to the World Health Organization (WHO), “Cardiovascular disease (CVD) is a leading public health (and economic issue) in the United States,” a fact
Navigating patient access barriers to solve public health challenges in CVD Read More »
The COVID-19 pandemic had a notably unprecedented impact on the world. Its lasting effects on society, economics, and healthcare have initiated a global discussion
5 lessons learned from COVID-19 Read More »
We have gene editing because of women—after all, Nobel Laureates Jennifer Doudna and Emmanuelle Charpentier discovered CRISPR Cas9, which kickstarted the gene-editing revolution. But
Women kickstarted the gene-editing revolution—and continue to lead the way Read More »
Locally transmitted cases of malaria have been detected in the United States for the first time in 20 years, the Centers for Disease Control
First locally transmitted malaria cases in U.S. since 2003 may be linked to climate Read More »
In the vaccine delivery industry, the need for disruption is clear. Today, more than 1.5 million people globally die each year from diseases for
Why a vaccine patch could be a game changer Read More »
Although further research is being conducted to ease potential concerns, the recommended childhood vaccines are safe and provide essential protection, experts told a June
Benefits of childhood vaccination outweigh possible risks, experts tell CDC Read More »
A cancer diagnosis is overwhelming, affecting not only a patient’s biology, but also their mental health, psycho-social status, and practical life (e.g., lives of
Cancer and mental health: improving equity and access to quality care Read More »
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) met on June 12-13, 2023, and announced the formation of
ICH announces discussion group on cell and gene therapy harmonization Read More »
A June 21 House hearing on health care costs put a sharp focus on the need for transparency to prevent pharmacy benefit managers (PBMs)
House hearing puts focus on need for PBM transparency Read More »
